{
  "id": 4964837,
  "title": "Xeris Biopharma’s Beth Hecht sells $141,434 in company stock",
  "url": "https://urgent.news/2026/09/01/xeris-biopharmas-beth-hecht-sells-141-434-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-01T23:30:55.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/xeris-biopharmas-beth-hecht-sells-141434-in-company-stock-93CH-4884734"
  },
  "original_language": "en",
  "account": null,
  "summary": "Xeris Biopharma's Chief Legal Officer and Corporate Secretary, Beth Hecht, sold 16,666 shares of the company's common stock on September 1, 2026, generating $141,434. The shares were sold at prices ranging from $8.390 to $8.600, with a weighted average sale price of $8.4864. This sale occurred under a Rule 10b5-1 trading plan that Hecht established on August 8, 2025. Despite the sale, Xeris shares have seen a 37.75% return over the past six months, though the stock is currently trading above its InvestingPro Fair Value, indicating potential overvaluation. Xeris Biopharma, valued at $1.54 billion, has impressive gross profit margins of 86.58%, even though it has not been profitable over the last twelve months. The company reported a revenue of $92.1 million in the second quarter of 2026, a 29% increase from the previous year, driven by strong demand for RECORLEV and a rebound in sales of Gvoke. However, Xeris Biopharma posted a loss of $0.18 per share, missing analysts' expectations of a small profit of $0.01 per share due to a one-time non-cash GAAP charge related to convertible note remeasurement.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Indie semiconductor COO Wittmann sells $63,400 in stock",
        "url": "https://urgent.news/2026/09/01/indie-semiconductor-coo-wittmann-sells-63-400-in-stock",
        "published": "2026-09-01T23:21:39.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}